Could a diet of fruits and vegetables replace bicarbonate pills for kidney patients?

NCT ID NCT05113641

Ongoing Disease control Sponsor: Dylan MacKay Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study explores whether eating alkalizing fruits and vegetables, delivered to your home, can help manage metabolic acidosis in people with chronic kidney disease. The usual treatment, sodium bicarbonate, often causes side effects and doesn't always work. The trial will see if this dietary approach is practical and effective for patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: alkalizing fruits and vegetables
What this could lead to: If this approach works, it could offer a more natural and tolerable way to manage metabolic acidosis in chronic kidney disease, potentially reducing reliance on medication.
What could go wrong: This is a small feasibility trial with only 37 participants, so results may not apply widely. The intervention may not effectively control acidosis or may be difficult for patients to follow long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Acidosis chronic kidney disease chronic renal failure syndrome metabolic acidosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASES METABOLIC ACIDOSIS

Contacts and locations

Locations

Chronic Kidney Disease (Renal) ClinicQEII - Dickson Building

Halifax, Nova Scotia, B3H 2Y9, Canada
Seven Oaks General Hospital Chronic Disease Innovation Centre

Winnipeg, Manitoba, R2V 3M3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.